| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1990PNAS...87.6441S |
| P356 | DOI | 10.1073/PNAS.87.16.6441 |
| P932 | PMC publication ID | 54550 |
| P698 | PubMed publication ID | 2117282 |
| P5875 | ResearchGate publication ID | 21039315 |
| P50 | author | Michael Houghton | Q1927895 |
| Robert H. Purcell | Q2157414 | ||
| Harvey J. Alter | Q5677307 | ||
| Jody Rosenblatt | Q55715228 | ||
| P2093 | author name string | A J Weiner | |
| Y K Shimizu | |||
| M Shapiro | |||
| D C Wong | |||
| T Popkin | |||
| P2860 | cites work | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 |
| An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
| Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups | Q29620772 | ||
| Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. | Q37108044 | ||
| Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus | Q37683499 | ||
| Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis | Q37821429 | ||
| Transmissible agent in non-A, non-B hepatitis | Q39480378 | ||
| Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees | Q41653018 | ||
| Detection of hepatitis C viral sequences in non-A, non-B hepatitis. | Q43564387 | ||
| Determining the size of non-A, non-B hepatitis virus by filtration | Q45833936 | ||
| Cytoplasmic antigen in hepatocytes of chimpanzees infected with non-A, non-B hepatitis virus or hepatitis delta virus: relationship to interferon | Q45847018 | ||
| Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non-A, non-B hepatitis in chimpanzees and their relation to D hepatitis. | Q52849252 | ||
| Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis. | Q52850277 | ||
| Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. | Q52850292 | ||
| Non-A, non-B hepatitis in chimpanzees and marmosets. | Q52850814 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 6441-6444 | |
| P577 | publication date | 1990-08-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Early events in hepatitis C virus infection of chimpanzees | |
| P478 | volume | 87 |
| Q42984278 | A long-term study of hepatitis C virus replication in non-A, non-B hepatitis |
| Q42981775 | A novel semi-automated paramagnetic microparticle based enzyme immunoassay for hepatitis C virus: its application to serologic testing |
| Q27486061 | A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants |
| Q54988623 | Animal Models to Study Hepatitis C Virus Infection. |
| Q42994244 | Assay for hepatitis C virus in peripheral blood mononuclear cells enhances sensitivity of diagnosis and monitoring of HCV-associated hepatitis |
| Q33702348 | Cell-based and animal models for hepatitis B and C viruses |
| Q34140014 | Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models |
| Q27480383 | Characterization of long-term cultures of hepatitis C virus |
| Q39628327 | Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus |
| Q45761050 | Comparative features of hepatitis C virus infection in humans and chimpanzees |
| Q29620057 | Course and outcome of hepatitis C |
| Q36767655 | Cryoglobulinemia related to hepatitis C virus infection |
| Q24288990 | Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization |
| Q27485648 | Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing |
| Q36890689 | Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology |
| Q27478449 | Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma |
| Q27488855 | Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees |
| Q27487987 | Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus |
| Q27486195 | Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes |
| Q27473088 | Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection |
| Q43035904 | Evidence against the role of hepatitis C virus in severe liver damage occurring early in the course of acute leukemia in children |
| Q34996679 | Experimental models for hepatitis C viral infection |
| Q37945172 | HCV animal models: a journey of more than 30 years |
| Q68264325 | Hepatitis C virus |
| Q38086753 | Hepatitis C virus RNA replication |
| Q43036529 | Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis |
| Q35034273 | Hepatitis C virus-induced cytoplasmic organelles use the nuclear transport machinery to establish an environment conducive to virus replication |
| Q36642065 | Hepatitis C: progress and problems |
| Q36124729 | Host cell targets in HCV therapy: novel strategy or proven practice? |
| Q33989160 | Humoral immune response in acute hepatitis C virus infection |
| Q27469647 | Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees |
| Q37493934 | Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein |
| Q37224855 | Infection of Common Marmosets with GB Virus B Chimeric Virus Encoding the Major Nonstructural Proteins NS2 to NS4A of Hepatitis C Virus |
| Q43037473 | Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. |
| Q35072828 | Isolation and characterization of highly replicable hepatitis C virus genotype 1a strain HCV-RMT |
| Q42984325 | Isolation of a complementary DNA fragment of hepatitis C virus in Taiwan revealed significant sequence variations compared with other isolates |
| Q29620909 | Lack of Protective Immunity Against Reinfection with Hepatitis C Virus |
| Q43039243 | Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q42993083 | Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan |
| Q41201723 | Mixed cryoglobulinemia secondary to hepatitis C virus infection |
| Q36441749 | Molecular biology of non-A, non-B hepatitis agents: hepatitis C and hepatitis E viruses |
| Q27477559 | Nonstructural Protein Precursor NS4A/B from Hepatitis C Virus Alters Function and Ultrastructure of Host Secretory Apparatus |
| Q27485755 | Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization |
| Q24649611 | Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation |
| Q33853655 | Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection |
| Q34499902 | Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant |
| Q27472983 | Polymerase chain reaction for the diagnosis of viral hepatitis B and C. |
| Q42017672 | Posttransfusion Hepatitis in Japan |
| Q43038527 | Prevalence of hepatitis C virus infection among long‐term hemodialysis patients: Detection of hepatitis C virus RNA in plasma |
| Q29615898 | Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization |
| Q40877566 | Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA. |
| Q41060159 | Replication of hepatitis C virus |
| Q36684658 | Review of hepatitis C in Japan |
| Q43046731 | Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany |
| Q27480841 | Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees |
| Q42984297 | Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees |
| Q27487982 | Serological markers of posttransfusion hepatitis C viral infection |
| Q40961683 | Substitution rates in hepatitis delta virus |
| Q24609524 | The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae |
| Q42981599 | The association of serum hepatitis C virus RNA with serum aminotransferase activities |
| Q37576273 | The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis |
| Q35743655 | The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. |
| Q42979832 | The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha |
| Q42981117 | Three different patterns of hepatitis C virus infection in chimpanzees |
| Q35105687 | Tissue culture and animal models for hepatitis C virus |
| Q27485872 | Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee |
| Q26865471 | Transfusion transmission of HCV, a long but successful road map to safety |
| Q35581216 | Ultrastructural alterations and expression of cytoplasmic antigen 48-1 in hepatocytes in association with hepatitis C virus infection |
| Q39148859 | Ultrastructural and biochemical basis for hepatitis C virus morphogenesis. |
| Q30669466 | Ultrastructural observations in hepatitis C virus-infected lymphoid cells |
| Q34375675 | Viral markers in the treatment of hepatitis B and C |
| Q35228510 | Virology, Molecular Biology, and Serology of Hepatitis C Virus |
Search more.